产品介绍：
产品说明
生化/生理作用
Structural modification of diphosphoryl lipid A by hydrolysis produces MPLA (monophosphoryl lipid A) and is known to decrease its toxicity. MPLA, a lipopolysaccharide derivative, acts an immunomodulator and is non-toxic. For this reason, it is useful as a vaccine adjuvant. The MPLA induced immune response is tissue specific. It enhances host′s resistance against endotoxin induced effects. It also decreases cytokine production during infection.
包装
2 mL Amber Glass Crimp Cap Vial (699854P-5mg)
2 mL Amber Glass Crimp Cap Vial (699854P-1mg)
其他说明
For R&D use only. Not for drug, household, or other uses.
基本信息
| 经验(实验)分子式 | C68H132N3O19P |
| 分子量 | 1326.76 |
| NACRES | NA.25 |
产品性质
| 测定 | >99% (HPLC) |
| 形式 | powder |
| 包装 | pkg of 1 × 1 mg (699854P-1mg) pkg of 1 × 5 mg (699854P-5mg) |
| manufacturer/tradename | Avanti Polar Lipids 699854P |
| 运输 | dry ice |
| 储存温度 | −20℃ |
| SMILES string | O[C@H]([C@@H](CO[C@@H]([C@@H]1NC(C[C@H](OC(CCCCCCCCCCCCC)=O)CCCCCCCCCCC)=O)O[C@H](CO)[C@@H](OP([O-])(O)=O)[C@@H]1O)O[C@H](O)[C@@H]2NC(C[C@H](O)CCCCCCCCCCC)=O)[C@@H]2OC(C[C@H](O)CCCCCCCCCCC)=O.[NH4+] |
安全信息
| 储存分类代码 | 13 - Non Combustible Solids |
| WGK | WGK 3 |
